Literature DB >> 7621488

Successful chemoradiation therapy for high-grade skull base chondrosarcoma in a child.

T Yoshimoto1, Y Sawamura, J Ikeda, N Ishii, H Abe.   

Abstract

High-grade chondrosarcoma in the skull base has been known to be extremely refractory to adjuvant therapy. We report successful chemoradiation therapy for skull base chondrosarcoma in a child. The patient was a 6-year-old boy with an invasive skull base tumor. In spite of gross total removal of the tumor, it recurred 1 month after surgery. Following an intra-arterial injection of adriamycin (10 mg), the second gross total removal was carried out. At the end of the operation, cisplatin (20 mg) was locally injected into the surgical cavity. The patient was further given a total of six courses of systemic chemotherapy in combination with adriamycin (30 mg/m2) and cisplatin (100 mg/m2) and 55 Gy focal irradiation. One year after the most recent surgery, the patient is in complete remission. The efficacy of adjuvant therapy of this rare tumor is discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7621488     DOI: 10.1007/bf00277662

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  19 in total

1.  Parasellar chondrosarcoma--case report.

Authors:  T Masuzawa; N Nakahara; K Saito; F Sato
Journal:  Neurol Med Chir (Tokyo)       Date:  1986-01       Impact factor: 1.742

2.  Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading.

Authors:  H L Evans; A G Ayala; M M Romsdahl
Journal:  Cancer       Date:  1977-08       Impact factor: 6.860

3.  Chondrosarcoma of the skull base.

Authors:  J F Kveton; D E Brackmann; M E Glasscock; W F House; W E Hitselberger
Journal:  Otolaryngol Head Neck Surg       Date:  1986-01       Impact factor: 3.497

4.  Cranial computed tomographic appearance of chondrosarcoma of the base of the skull.

Authors:  R I Grossman; K R Davis
Journal:  Radiology       Date:  1981-11       Impact factor: 11.105

5.  Intraperitoneal cisplatin and etoposide in the treatment of refractory/recurrent ovarian carcinoma.

Authors:  B Reichman; M Markman; T Hakes; W Hoskins; S Rubin; W Jones; L Almadrones; M Ochoa; D Chapman; P Saigo
Journal:  J Clin Oncol       Date:  1989-09       Impact factor: 44.544

6.  Chordoma and chondrosarcoma of the cranial base: an 8-year experience.

Authors:  C N Sen; L N Sekhar; V L Schramm; I P Janecka
Journal:  Neurosurgery       Date:  1989-12       Impact factor: 4.654

7.  Chondrosarcomas of the skull base: MR imaging features.

Authors:  S P Meyers; W L Hirsch; H D Curtin; L Barnes; L N Sekhar; C Sen
Journal:  Radiology       Date:  1992-07       Impact factor: 11.105

8.  [A case of chondrosarcoma in the cavernous sinus].

Authors:  H Koga; J Mukawa; K Miyagi; T Kinjo; T Harakuni
Journal:  No Shinkei Geka       Date:  1991-12

9.  Radiotherapy of chondrosarcoma of bone.

Authors:  A R Harwood; J I Krajbich; V L Fornasier
Journal:  Cancer       Date:  1980-06-01       Impact factor: 6.860

Review 10.  Extracranial skull base chondrosarcoma.

Authors:  M D Seidman; R D Nichols; U B Raju; B Mehta; H G Levy
Journal:  Ear Nose Throat J       Date:  1989-08       Impact factor: 1.697

View more
  4 in total

1.  Cranial chondrosarcoma and recurrence.

Authors:  Orin G Bloch; Brian J Jian; Isaac Yang; Seunggu J Han; Derick Aranda; Brian J Ahn; Andrew T Parsa
Journal:  Skull Base       Date:  2010-05

Review 2.  Postsurgical management strategies in patients with skull base chondrosarcomas.

Authors:  Aditya Iyer; Hideyuki Kano; Douglas Kondziolka; Xiaomin Liu; John C Flickinger; L Dade Lunsford
Journal:  CNS Oncol       Date:  2013-03

Review 3.  A systematic review of intracranial chondrosarcoma and survival.

Authors:  Orin G Bloch; Brian J Jian; Isaac Yang; Seunggu J Han; Derick Aranda; Brian J Ahn; Andrew T Parsa
Journal:  J Clin Neurosci       Date:  2009-09-30       Impact factor: 1.961

Review 4.  Intracranial chondrosarcoma: review of the literature and report of 15 cases.

Authors:  A G Korten; H J ter Berg; G H Spincemaille; R T van der Laan; A M Van de Wel
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-07       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.